Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes

Jennifer E Ten Eyck1 Department of Urology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, USA

https://orcid.org/0000-0002-5504-8672

Navkirat Kahlon2 Department of Hematology Oncology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, USA

Sonia Masih1 Department of Urology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, USA

Danae M Hamouda2 Department of Hematology Oncology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, USA

Firas G Petros1 Department of Urology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, USACorrespondence[email protected]

https://orcid.org/0000-0003-3062-0780

Figures & data

Figure 1 PRISMA flow diagram demonstrates identifications of studies via databases used for literature review, screening and final cohort of studies included in this review.

Table 1 Overview of Peer-Review Avelumab Trials Reviewed

Download CSV Display Table

Table 2 Published Avelumab Patient Outcomes of Reviewed Papers

Download CSV Display Table

Table 3 Combined Summary of Adverse Events in Apolo et al and Powles et al for 593 Patients^{Citation7,Citation9}

Download CSV Display Table

Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes

Table 1 Overview of Peer-Review Avelumab Trials Reviewed

Table 2 Published Avelumab Patient Outcomes of Reviewed Papers

Table 3 Combined Summary of Adverse Events in Apolo et al and Powles et al for 593 Patients^{Citation7,Citation9}

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes

Figures & data

Table 1 Overview of Peer-Review Avelumab Trials Reviewed

Table 2 Published Avelumab Patient Outcomes of Reviewed Papers

Table 3 Combined Summary of Adverse Events in Apolo et al and Powles et al for 593 PatientsCitation7,Citation9

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 3 Combined Summary of Adverse Events in Apolo et al and Powles et al for 593 Patients^{Citation7,Citation9}